Neurocrine Biosciences
1 / 1
Failed to load
Bioscience
Neurocrine Biosciences Presents Breadth of Data Over Time Following Treatment With INGREZZA Capsules
Neurocrine Biosciences
PR-10-24-NI-71Nov 04, 2024
Failed to load
Drug Development
Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders
Takeda
PR-M06-20-NI-019Jun 16, 2020
Failed to load
Drug Development
Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2018 World Congress on Parkinson's Disease and Related Disorders
Neurocrine Biosciences
PR-M09-18-NI-058Sep 20, 2018
1 / 1